aptt reagent (Dade Behring)
Structured Review
Aptt Reagent, supplied by Dade Behring, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/aptt+reagents/aptt+reagent/us12617839-1400-11-17
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: A comparison of the sensitivity of APTT reagents to the effects of enoxaparin, a low-molecular weight heparin Article Snippet: Low-molecular weight heparin (LMWH) is the product of enzymatic or chemical degradation of unfractionated heparin (UFH).. It has been found to have better bio-availibility, more predictable dose response and can be used as an alternative to UFH for prophylaxis and treatment of thrombotic disorders.. It is claimed that no laboratory monitoring is necessary for LMWH therapy; however, for the aged, renal impaired, obese or grossly underweight, monitoring of dose effect with anti-Xa assay is recommended. Article Title: A sample-to-result system for blood coagulation tests on a microfluidic disk analyzer Article Snippet: Materials Both PT and Article Title: A sample-to-result system for blood coagulation tests on a microfluidic disk analyzer Article Snippet: Both PT and Article Title: Potential Inhibitory Effects on Human Platelet Aggregation and blood Coagulation of the Aerial Part of Portulaca oleracea L Article Snippet: This work is licensed under the Creative Commons Attribution 4.0 International License APTT (activated partial thromboplastin time) and TT ( Recombinant:Article Title: Bispecific antibody substituting for functional proteins Article Snippet: A mixture of 40 μL antibody solution (25 μg/mL) and 50 μL F.VIII-deficient plasma (Biomerieux) was incubated at room temperature for 30 minutes. .. To this mixture, 10 μL of the recombinant blood coagulation factor VIII formulation Kogenate® FS (BAYER) and 50 μL Coagulation:Article Title: Bispecific antibody substituting for functional proteins Article Snippet: A mixture of 40 μL antibody solution (25 μg/mL) and 50 μL F.VIII-deficient plasma (Biomerieux) was incubated at room temperature for 30 minutes. .. To this mixture, 10 μL of the recombinant blood coagulation factor VIII formulation Kogenate® FS (BAYER) and 50 μL Formulation:Article Title: Bispecific antibody substituting for functional proteins Article Snippet: A mixture of 40 μL antibody solution (25 μg/mL) and 50 μL F.VIII-deficient plasma (Biomerieux) was incubated at room temperature for 30 minutes. .. To this mixture, 10 μL of the recombinant blood coagulation factor VIII formulation Kogenate® FS (BAYER) and 50 μL |
